24
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Oral signs of acute leukemia for early detection

      case-report

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Purpose

          Systemic disease can manifest oral signs at an early phase, which may be crucial for the diagnosis and timing of treatment. This report describes two patients who presented with gingival enlargement as an early sign of acute leukemia.

          Methods

          Two patients presented with oral symptoms including severe gingival enlargement. The progress of their symptoms was associated with underlying systemic disease.

          Results

          The patients were transferred to the Department of Hematology and diagnosed with acute myelomonocytic leukemia. They received appropriate treatment and survived.

          Conclusions

          Gingival enlargement can be caused by underlying systemic diseases. Accurate diagnosis and timely referral are important for preventing a fatal situation. It must be emphasized that some oral signs and symptoms may be closely correlated with systemic diseases.

          Graphical Abstract

          Related collections

          Most cited references32

          • Record: found
          • Abstract: found
          • Article: not found

          The World Health Organization (WHO) classification of the myeloid neoplasms.

          A World Health Organization (WHO) classification of hematopoietic and lymphoid neoplasms has recently been published. This classification was developed through the collaborative efforts of the Society for Hematopathology, the European Association of Hematopathologists, and more than 100 clinical hematologists and scientists who are internationally recognized for their expertise in hematopoietic neoplasms. For the lymphoid neoplasms, this classification provides a refinement of the entities described in the Revised European-American Lymphoma (REAL) Classification-a system that is now used worldwide. To date, however, there has been no published explanation or rationale given for the WHO classification of the myeloid neoplasms. The purpose of this communication is to outline briefly the WHO classification of malignant myeloid diseases, to draw attention to major differences between it and antecedent classification schemes, and to provide the rationale for those differences.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Acute myeloid leukaemia.

            Acute myeloid leukaemia (AML) is a heterogeneous clonal disorder of haemopoietic progenitor cells and the most common malignant myeloid disorder in adults. The median age at presentation for patients with AML is 70 years. In the past few years, research in molecular biology has been instrumental in deciphering the pathogenesis of the disease. Genetic defects are thought to be the most important factors in determining the response to chemotherapy and outcome. Whereas significant progress has been made in the treatment of younger adults, the prospects for elderly patients have remained dismal, with median survival times of only a few months. This difference is related to comorbidities associated with ageing and to disease biology. Current efforts in clinical research focus on the assessment of targeted therapies. Such new approaches will probably lead to an increase in the cure rate.
              Bookmark
              • Record: found
              • Abstract: not found
              • Article: not found

              Proposed revised criteria for the classification of acute myeloid leukemia. A report of the French-American-British Cooperative Group.

                Bookmark

                Author and article information

                Journal
                J Periodontal Implant Sci
                J Periodontal Implant Sci
                JPIS
                Journal of Periodontal & Implant Science
                Korean Academy of Periodontology
                2093-2278
                2093-2286
                December 2014
                31 December 2014
                : 44
                : 6
                : 293-299
                Affiliations
                [1 ]Department of Periodontology, Research Institute for Periodontal Regeneration, Yonsei University College of Dentistry, Seoul, Korea.
                [2 ]Department of Applied Life Science, BK21 PLUS Project, Yonsei University College of Dentistry, Seoul, Korea.
                Author notes
                Correspondence: Chang-Sung Kim. Department of Periodontology, Research Institute for Periodontal Regeneration, Department of Applied Life Science, Yonsei University College of Dentistry, 50 Yonsei-ro, Seodaemun-gu, Seoul 120-752, Korea. dentall@ 123456yuhs.ac , Tel: +82-2-2228-3186, Fax: +82-2-392-0398
                Author information
                http://orcid.org/0000-0001-7695-1708
                http://orcid.org/0000-0003-3902-1071
                Article
                10.5051/jpis.2014.44.6.293
                4284378
                25568810
                1c9f3521-97c3-4e12-ae23-bae30c6b397d
                Copyright © 2014 Korean Academy of Periodontology

                This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( http://creativecommons.org/licenses/by-nc/3.0/).

                History
                : 11 November 2014
                : 11 December 2014
                Categories
                Case Report

                Dentistry
                dentist,gingival hyperplasia,leukemia
                Dentistry
                dentist, gingival hyperplasia, leukemia

                Comments

                Comment on this article